<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Surg.</journal-id><journal-title-group>
<journal-title>Frontiers in Surgery</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Surg.</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2296-875X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fsurg.2026.1651583</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Precise balloon pressure regulation in percutaneous balloon compression for trigeminal neuralgia: evidence from a single-center prospective cohort</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Fei</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/3103894/overview"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role></contrib>
<contrib contrib-type="author"><name><surname>Guo</surname><given-names>Kun</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/2642684/overview" /><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role></contrib>
<contrib contrib-type="author"><name><surname>Sun</surname><given-names>Qihao</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role></contrib>
<contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Jian</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role></contrib>
<contrib contrib-type="author"><name><surname>Yu</surname><given-names>Bingwen</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Peng</surname><given-names>ShaoPeng</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Department of Neurointervention, Shaoguan First People&#x0027;s Hospital, Affiliated Hospital of Shaoguan University</institution>, <city>Shaoguan</city>, <state>Guangdong</state>, <country country="cn">China</country></aff>
<aff id="aff2"><label>2</label><institution>Department of Neurosurgery, Gansu Provincial People&#x2019;s Hospital</institution>, <city>Lanzhou</city>, <state>Gansu</state>, <country country="cn">China</country></aff>
<aff id="aff3"><label>3</label><institution>Department of Neurology, Xi&#x0027;an Central Hospital</institution>, <city>Xi&#x0027;an</city>, <state>Shaanxi</state>, <country country="cn">China</country></aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> ShaoPeng Peng <email xlink:href="mailto:bianfen@163.com">bianfen@163.com</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-03-10"><day>10</day><month>03</month><year>2026</year></pub-date>
<pub-date publication-format="electronic" date-type="collection"><year>2026</year></pub-date>
<volume>13</volume><elocation-id>1651583</elocation-id>
<history>
<date date-type="received"><day>28</day><month>06</month><year>2025</year></date>
<date date-type="rev-recd"><day>14</day><month>01</month><year>2026</year></date>
<date date-type="accepted"><day>26</day><month>01</month><year>2026</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2026 Wang, Guo, Sun, Zhang, Yu and Peng.</copyright-statement>
<copyright-year>2026</copyright-year><copyright-holder>Wang, Guo, Sun, Zhang, Yu and Peng</copyright-holder><license><ali:license_ref start_date="2026-03-10">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license>
</permissions>
<abstract><sec><title>Background</title>
<p>Trigeminal neuralgia (TN) causes severe paroxysmal facial pain and quality-of-life impairment. Percutaneous balloon compression (PBC) is minimally invasive, yet efficacy and complication rates remain variable. We conducted a single-centre prospective cohort study to define phase-specific intraballoon pressure thresholds that maximize pain relief while minimising facial hypoaesthesia and recurrence.</p>
</sec><sec><title>Methods</title>
<p>115-TN patients undergoing PBC (Jan 2017&#x2013;Aug 2024) had real-time pressure recorded at 1&#x2005;Hz. Pressure morphometrics were classified into pear-shaping, maintenance and full-compression phases. Reference intervals (RI) were established with the non-parametric CLSI C28-A2 method (<italic>n</italic>&#x2009;&#x2265;&#x2009;4,000 measurements per phase). Associations between phase pressures and 24-h hypoaesthesia grade or 24-month recurrence were examined with Spearman correlation and Cox regression (Schoenfeld validation).</p>
</sec><sec><title>Results</title>
<p>Higher phase pressures correlated with more severe hypoaesthesia (<italic>&#x03C1;</italic>&#x2009;&#x003D;&#x2009;0.44&#x2013;0.62, <italic>P</italic>&#x2009;&#x003C;&#x2009;0.01), whereas lower pressures predicted increased recurrence (HR&#x2009;&#x003D;&#x2009;0.87 per 5&#x2005;kPa, 95&#x0025; CI 0.80&#x2013;0.94, <italic>P</italic>&#x2009;&#x003D;&#x2009;0.002). Optimal RI were: pear-shaping 126.5&#x2013;156.8&#x2005;kPa, maintenance 117.9&#x2013;136.1&#x2005;kPa, full-compression 119.9&#x2013;141.9&#x2005;kPa. Operating within these bands produced BNI-I/II pain relief in 98&#x0025; of patients with only 16&#x0025; transient Grade-III hypoaesthesia.</p>
</sec><sec><title>Conclusion</title>
<p>Real-time, phase-adapted pressure control within the proposed RI allows surgeons to standardize PBC while individualizing the therapeutic window, improving safety and durability of pain relief.</p>
</sec>
</abstract>
<kwd-group>
<kwd>balloon pressure</kwd>
<kwd>percutaneous balloon compression</kwd>
<kwd>postoperative complications</kwd>
<kwd>precision surgery</kwd>
<kwd>trigeminal neuralgia</kwd>
</kwd-group><funding-group><funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This study was supported by the Gansu Provincial People&#x2019;s Hospital Intramural Research Fund Project, including project 21GSSYB-12 and project 22GSSYB-15, both of which are general projects, as well as the Gansu Natural Science Foundation under Grant 21JR11RA193.</funding-statement></funding-group><counts>
<fig-count count="7"/>
<table-count count="5"/><equation-count count="0"/><ref-count count="27"/><page-count count="13"/><word-count count="0"/></counts><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Neurosurgery</meta-value></custom-meta></custom-meta-group>
</article-meta>
</front>
<body><sec id="s1" sec-type="intro"><label>1</label><title>Introduction</title>
<p>Trigeminal Neuralgia (TN) is a neuropathic pain disorder marked by severe facial pain, which can considerably reduce the patient&#x0027;s quality of life (<xref ref-type="bibr" rid="B1">1</xref>). Percutaneous balloon compression (PBC), initially described by Mullan and Lichtor in 1983, achieves mechanical ablation of the trigeminal ganglion through controlled balloon inflation (<xref ref-type="bibr" rid="B2">2</xref>). Compared with microvascular decompression (MVD), PBC offers distinct advantages including shorter operative duration, reduced morbidity, and minimal invasiveness (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). These attributes render it particularly suitable for elderly patients, those medically unfit for prolonged general anaesthesia, or individuals declining open cranial surgery (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). Through iterative refinements, PBC has evolved into a widely adopted minimally invasive intervention for TN.</p>
<p>PBC outcomes are influenced by multiple technical factors, including balloon morphology, volume, compression duration, and pressure (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). Current consensus indicates optimal efficacy when the balloon assumes a &#x201C;pear-shaped&#x201D; morphology intraoperatively, with a compression duration of 120&#x2013;180&#x2005;s yielding favorable results. Sun et al (<xref ref-type="bibr" rid="B9">9</xref>). evaluated over 150 PBC cases with two-year follow-up, reporting near-complete pain resolution (approaching 100&#x0025;) when lateral fluoroscopy confirmed pear-shaped balloon formation. This finding aligns with conclusions by P&#x00E4;r Asplund et al. Notably, Huo et al. utilised Dyna-CT reconstruction to demonstrate superior outcomes with balloon volumes of 568.2&#x2013;891.4&#x2005;mm<sup>3</sup>, correlating with an elliptical morphology (<xref ref-type="bibr" rid="B10">10</xref>). Regarding compression duration, most studies support 1&#x2013;3&#x2005;min as clinically effective. Some surgeons advocate 60&#x2005;s as a minimum threshold for adequate analgesia (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>). This is corroborated by animal studies showing effective nociceptive blockade in Oryctolagus cuniculus (rabbit) models at 2-minute compression (<xref ref-type="bibr" rid="B13">13</xref>).</p>
<p>While optimal pear-shaped morphology, appropriate balloon volume, and precise compression duration constitute necessary prerequisites for percutaneous balloon compression (PBC), intraoperative pressure regulation emerges as the paramount factor governing therapeutic efficacy and safety (<xref ref-type="bibr" rid="B14">14</xref>). Excessive pressures (&#x003E;250&#x2005;kPa) precipitate balloon rupture with contrast extravasation, significantly elevating risks of postoperative hypoaesthesia and masticatory weakness. Conversely, inadequate pressures (&#x003C;130&#x2005;kPa) compromise pain relief and heighten recurrence rates. Empirical evidence substantiates this paradigm: Brown et al. documented a mean intraballoon pressure of 109.5&#x2009;&#x00B1;&#x2009;45.2&#x2005;kPa correlating with favorable outcomes (<xref ref-type="bibr" rid="B15">15</xref>), while Wang et al. identified an optimal therapeutic window of 132&#x2013;162&#x2005;kPa (converted from 1.3&#x2013;1.6&#x2005;atm) for balancing efficacy and morbidity (<xref ref-type="bibr" rid="B16">16</xref>). Notwithstanding these insights, current clinical practice remains constrained by two critical limitations: 1) commercial catheter systems lack integrated manometry capabilities, and 2) surgeons rely on subjective pressure estimation without quantitative benchmarks. This evidence gap necessitates the implementation of precision intraoperative manometry to establish robust pressure-efficacy-safety correlations and define phase-specific therapeutic thresholds&#x2014;imperative advancements for standardizing PBC protocols and optimizing patient outcomes.</p>
<p>This study employed a custom-developed manometry system engineered by our research team to monitor intraoperative balloon pressure dynamics in real-time. Post-procedural analysis characterized pressure trajectory profiles, enabling phase-based classification according to morphological transitions. Subsequent correlation analyses examined relationships between phase-specific pressure parameters and postoperative complications, thereby generating clinical and theoretical evidence to advance precision medicine in trigeminal neuralgia management.</p>
</sec>
<sec id="s2"><label>2</label><title>Material and methods</title>
<sec id="s2a"><label>2.1</label><title>Study population</title>
<p>A prospective cohort of 115 patients with primary trigeminal neuralgia (TN) underwent percutaneous balloon compression (PBC) at the Department of Neurosurgery, Gansu Provincial People&#x0027;s Hospital between January 2017 and August 2024 (<xref ref-type="fig" rid="F1">Figure&#x00A0;1</xref>).</p>
<fig id="F1" position="float"><label>Figure&#x00A0;1</label>
<caption><p>Flowchart of inclusion and exclusion criteria.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fsurg-13-1651583-g001.tif"><alt-text content-type="machine-generated">Flowchart showing the treatment pathway of 407 patients diagnosed with primary neuralgia. Out of these, 134 underwent PBC surgery. Eighteen patients were excluded due to various conditions. One case had persistent pain with a \"pear-shaped\" presentation during surgery. Of the remaining 115 cases with postoperative pain relief, 108 experienced no recurrence, while 7 had a recurrence. After two years, 98 continued without recurrence, and 17 had recurring symptoms. Another group of 273 patients received conservative treatment or MVD surgery.</alt-text>
</graphic>
</fig>
<sec id="s2a1"><label>2.1.1</label><title>Inclusion criteria</title>
<p>Diagnosis of primary TN according to the Chinese Expert Consensus on Trigeminal Neuralgia, aligning with ICHD-3 diagnostic criteria (code 13.1.1.1); Failure or intolerance to &#x2265;6 months of pharmacological therapy (carbamazepine/oxcarbazepine first-line) with contraindications to or refusal of open cranial surgery; Intraoperative confirmation of pear-shaped balloon morphology; Provision of written informed consent by patients and legal guardians.</p>
</sec>
<sec id="s2a2"><label>2.1.2</label><title>Exclusion criteria</title>
<p>Skull base CT 3D-reconstruction demonstrating foramen ovale malformation or positional anomalies; Secondary TN ruled out by contrast-enhanced cranial MRI; Comorbid craniofacial neurological disorders or severe cardiopulmonary dysfunction (NYHA Class III/IV or GOLD Stage 3/4); Preoperative ECG or echocardiography revealing significant arrhythmias or severe valvular defects.</p>
<p>The study protocol complied with the Declaration of Helsinki (2013 revision) and received ethical approval from the Institutional Review Board of Gansu Provincial People&#x0027;s Hospital (Approval No: 2022-072). Written informed consent was obtained from all participants.</p>
</sec>
</sec>
<sec id="s2b"><label>2.2</label><title>Operative technique</title>
<p>Before surgery, remove the inner core of the balloon catheter (a single - use neurosurgical balloon catheter kit, model QKS - 0050005, from Shenzhen Qingyuan Medical Instruments Co., Ltd.). Connect its end to the front port of a three - way tube. Link the three - way tube&#x0027;s side port to a manometer (an AZ8230 digital pressure gauge from Taiwan&#x0027;s Heng Hsin Company), and connect the gauge to computer recording software (AZInstrumentCorp, handheld instrument data - logging software, version 3.10). Attach a 2.5 - mL syringe containing 2.0&#x2005;mL iohexol to the rear port of the three - way tube. Inject about 1&#x2005;mL iohexol into the balloon catheter to check the balloon&#x0027;s integrity. Repeatedly inflate and aspirate several times to remove air from the balloon, and set it aside for later use (<xref ref-type="fig" rid="F2">Figure&#x00A0;2</xref>).</p>
<fig id="F2" position="float"><label>Figure&#x00A0;2</label>
<caption><p>Surgical pressure testing instrument diagram. 1. Balloon catheter 2. Balloon 3. Balloon connector 31, 32. The medical three - way tubes 4. Infusion set connector 5. Manometer 6. Syringe.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fsurg-13-1651583-g002.tif"><alt-text content-type="machine-generated">Diagram of a medical device setup, including a balloon catheter (1) attached to a balloon (2). It connects to a balloon connector (3) and medical three-way tubes (32). The infusion set connector (4) links to a manometer (5) and syringe (6).</alt-text>
</graphic>
</fig>
<p>All procedures were performed under monitored anaesthesia care with endotracheal intubation. Patients were positioned supine with continuous electrocardiographic and pulse oximetry monitoring. A modified Hartel anterior approach was utilized for foramen ovale cannulation. The entry point was located 2.5&#x2013;3.0&#x2005;cm lateral to the oral commissure on the affected side, directed medially toward the mid-pupillary line and posteriorly toward a point 3&#x2005;cm anterior to the external auditory meatus. After skin puncture with a 14-gauge needle, the cannula was advanced under fluoroscopic guidance. Upon confirming correct positioning within the foramen ovale, the cannula was advanced &#x223C;1&#x2005;cm intracranially. The stylet was then withdrawn, and the balloon catheter tip inserted through the cannula sheath into Meckel&#x0027;s cave along the mandibular nerve (V3). Under real-time fluoroscopy: 0.2&#x2005;mL iohexol was injected to initiate balloon inflation. Additional 0.2&#x2013;0.5&#x2005;mL iohexol was administered until optimal pear-shaped morphology was achieved (<xref ref-type="bibr" rid="B17">17</xref>). Pressure recording commenced (1&#x2005;Hz sampling) with the syringe barrel fixed. Upon detecting a&#x2009;&#x003E;&#x2009;30&#x0025; pressure drop, supplemental 0.1&#x2013;0.2&#x2005;mL iohexol was injected to restore baseline pressure &#x00B1;10&#x0025;. The syringe barrel was re-fixed until compression completion. Balloon compression was maintained for 150&#x2005;s in all cases. The cannula was withdrawn with 5-minute manual compression at the puncture site. Perioperative management: Atropine (0.5&#x2005;mg IV) was prepared for trigeminocardiac reflex prophylaxis. Postoperative antiviral prophylaxis (e.g., acyclovir 400&#x2005;mg TDS) prevented perioral herpes. Ocular lubricant ointment was applied to mitigate keratopathy (<xref ref-type="fig" rid="F3">Figure&#x00A0;3</xref>).</p>
<fig id="F3" position="float"><label>Figure&#x00A0;3</label>
<caption><p>The components required for the intraoperative pressure measurement setup. <bold>(A)</bold> Medical three-way stopcock. <bold>(B)</bold> Pressure transducer. <bold>(C)</bold> Puncture needle. <bold>(D)</bold> Syringe. <bold>(E)</bold> Balloon catheter. <bold>(F)</bold> disposable laparoscopic set. <bold>(I)</bold> The connection of the pressure transducer, three-way stopcock, balloon catheter, and syringe. <bold>(J)</bold> Equipment and computer manometric software connected for intraoperative fluproscopy.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fsurg-13-1651583-g003.tif"><alt-text content-type="machine-generated">Medical equipment displayed on a surgical drape includes a three-way stopcock, pressure transducer, puncture needle, syringe, balloon catheter, disposable laparoscopic set, and related items. Another image shows the connections of medical tools like the transducer and syringe. An additional image displays equipment and computer software set up for intraoperative fluoroscopy in an operating room setting.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2c"><label>2.3</label><title>Balloon pressure phases</title>
<p>Given uniform 150-second compression duration across all cases, pressure dynamics were classified into three consecutive phases:</p>
<p>Pear-Shaping Phase Initiated when fluoroscopy confirmed optimal pear-shaped morphology. Terminated upon detection of a rapid pressure decline (defined as &#x003E;15&#x0025; drop within 5&#x2005;s). During this phase: Mechanical deformation of dural layers within Meckel&#x0027;s cave occurs, facilitating ganglion compression.</p>
<p>Pressure range was recorded at 1-second intervals. 2. Pressure-Maintenance Phase Commencing after pear-shaping phase completion: Supplementary iohexol (0.1&#x2013;0.2&#x2005;mL) was administered to elevate pressure to 20&#x0025;&#x2013;30&#x0025; above the pear-shaping baseline. Continuous micro- injections maintained pressure within &#x00B1;10&#x0025; of target value. Pressure decay slope was quantified.</p>
<p>Full-Compression Phase: Encompassing the entire 150-second procedure from initial inflation to decompression. Integrated pressure metrics included: Time-weighted mean pressure Area under pressure-time curve (AUC).</p>
</sec>
<sec id="s2d"><label>2.4</label><title>Balloon pressure monitoring</title>
<p>The full-compression phase (150&#x2005;s in all cases, consistent with institutional protocol) spanned from initial pear-shaped formation to decompression. Pressure dynamics were stratified into two distinct intervals: Pear-Shaping Phase Initiation: Fluoroscopic confirmation of ideal pear-shaped morphology Termination: Objective detection of rapid pressure decay (operationalized as &#x003E;15&#x0025; decrease within 5&#x2005;s) Biomechanical Events: Transient dural deformation within Meckel&#x0027;s cave enabling effective ganglionic compression Data Capture: Continuous pressure recording at 1&#x2005;Hz sampling frequency Pressure-Maintenance Phase Commencement: Immediate post pear-shaping phase Pressure Modulation: Bolus injection of 0.1&#x2013;0.2&#x2005;mL iohexol to achieve 120&#x0025;&#x2013;130&#x0025; baseline pressure recovery Microadjustments maintaining pressure within &#x00B1;10&#x0025; target threshold Mechanical Objective: Sustain axonal compression via controlled meningeal displacement Quantitative Analysis: Linear regression of pressure decay gradient (kPa/s) (<xref ref-type="fig" rid="F4">Figure&#x00A0;4</xref>).</p>
<fig id="F4" position="float"><label>Figure&#x00A0;4</label>
<caption><p>Balloon shape changes during PBC puncture and corresponding pressure changes in the manometer. <bold>(A)</bold> Puncture needle reaches the foramen ovale; <bold>(B)</bold> during the procedure, the balloon takes on an &#x0022;under-inflated pear shape&#x0022;; <bold>(C)</bold> during the procedure, the balloon forms the ideal &#x0022;pear shape&#x0022;; <bold>(D)</bold> postoperative trend of reorganized balloon pressure.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fsurg-13-1651583-g004.tif"><alt-text content-type="machine-generated">Composite image of four panels labeled A, B, C, and D. Panel A shows a puncture needle reaching the foramen ovale. Panel B depicts a balloon with an under-inflated pear shape during the procedure. Panel C displays the balloon forming an ideal pear shape. Panel D illustrates a graph showing the postoperative trend of reorganized balloon pressure.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2e"><label>2.5</label><title>Statistical determination of pressure reference intervals</title>
<p>In this study, the pressure ranges for the balloon&#x0027;s pyriform phase, maintenance phase, and the entire procedure were calculated using the non-parametric method specified in the CLSI C28-A2 document. Initially, we excluded balloon pressure data from patients who experienced unrelieved pain 24&#x2005;h post-surgery or had pain recurrence at 12 months. The remaining data were sorted in ascending order, denoted as X&#x2081;, X&#x2082;, X&#x2083;,&#x2009;.., X<sub>n&#x2212;1</sub>, X<sub>n</sub>. Here, <italic>P</italic> represents the rank of each data point (<italic>P</italic>&#x2009;&#x003D;&#x2009;1&#x223C;n), with a sample size of <italic>n</italic> (<italic>n</italic>&#x2009;&#x003E;&#x2009;120). To determine the reference ranges, we calculated the ranks for the lower limit, <italic>P</italic> (0.5)&#x2009;&#x003D;&#x2009;0.005&#x2009;&#x00D7;&#x2009;(<italic>n</italic>&#x2009;&#x002B;&#x2009;1), and the upper limit, <italic>P</italic> (99.5)&#x2009;&#x003D;&#x2009;0.995&#x2009;&#x00D7;&#x2009;(<italic>n</italic>&#x2009;&#x002B;&#x2009;1). The corresponding balloon pressures for these ranks, <italic>P</italic><sub>0.5</sub> and <italic>P</italic><sub>99.5</sub>, established the reference range as P<sub>0.5</sub> to <italic>P</italic><sub>99.5</sub>. Additionally, we used the Kolmogorov&#x2013;Smirnov test to assess the distribution of time data for the pyriform and maintenance phases, checking for uniformity and calculating the mean time and fluctuation range (mean&#x2009;&#x00B1;<sans-serif>&#x2009;standard</sans-serif> deviation) to clearly define the time frames of these two phases. In the results section, the measured data were presented directly.</p>
</sec>
<sec id="s2f"><label>2.6</label><title>Relevant assessment criteria</title>
<sec id="s2f1"><label>2.6.1</label><title>Assessment of pain</title>
<p>Postoperative pain relief was evaluated at 24&#x2005;h using the Barrow Neurological Institute (BNI) Pain Intensity Score (<xref ref-type="bibr" rid="B18">18</xref>): Grade I: Pain-free without medication, Grade II: Occasional non-disabling pain, Grade III: Pain adequately controlled with medication, Grade IV: Significant pain refractory to medication, Grade V: Severe intractable pain, Treatment response was defined as: Effective: BNI Grades I&#x2013;II Ineffective: BNI Grades III&#x2013;V (<xref ref-type="table" rid="T1">Table&#x00A0;1</xref>). Pain recurrence criteria required: BNI Pain Intensity&#x2009;&#x2265;&#x2009;Grade II at the 12-month or 24 months follow-up visit. Subsequent scheduled assessments were performed at 12 and 24 months. All evaluations were conducted by consultant-level neurologists (minimum ten years&#x2019; experience); any discrepancies were resolved by a third blinded assessor.</p>
<table-wrap id="T1" position="float"><label>Table&#x00A0;1</label>
<caption><p>Barrow Neurological Institute (BNI) pain intensity grade.</p></caption>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Grade</th>
<th valign="top" align="center">Description</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">I</td>
<td valign="top" align="left">No pain</td>
</tr>
<tr>
<td valign="top" align="left">II</td>
<td valign="top" align="left">Occasional pain</td>
</tr>
<tr>
<td valign="top" align="left">III</td>
<td valign="top" align="left">Pain controlled with medication</td>
</tr>
<tr>
<td valign="top" align="left">IV</td>
<td valign="top" align="left">Pain not controlled with medication</td>
</tr>
<tr>
<td valign="top" align="left">V</td>
<td valign="top" align="left">Severe pain unrelieved</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2f2"><label>2.6.2</label><title>Assessment of hypoesthesia</title>
<p>Facial hypoaesthesia was evaluated at 24&#x2005;h and 12 months postoperatively using the BNI Facial Hypoaesthesia Scale: Grade I: No sensory deficit, Grade II: Mild hypoaesthesia without functional impairment, Grade III: Moderate hypoaesthesia affecting daily activities, Grade IV: Severe disabling hypoaesthesia, Clinically significant hypoaesthesia was defined as Grades II&#x2013;IV. Discrepancies underwent adjudication by a third blinded consultant. Follow-up combined outpatient reviews with structured telephone interviews by neurosurgeons trained in standardized assessment protocols (<xref ref-type="table" rid="T2">Table&#x00A0;2</xref>).</p>
<table-wrap id="T2" position="float"><label>Table&#x00A0;2</label>
<caption><p>Assessment of facial numbness using BNI facial numbness intensity grading.</p></caption>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">BNI grade</th>
<th valign="top" align="center">Description</th>
<th valign="top" align="center">Facial numbness occurrence</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">I</td>
<td valign="top" align="left">No pain</td>
<td valign="top" align="left">No</td>
</tr>
<tr>
<td valign="top" align="left">II</td>
<td valign="top" align="left">Occasional pain</td>
<td valign="top" align="left">Yes</td>
</tr>
<tr>
<td valign="top" align="left">III</td>
<td valign="top" align="left">Pain controlled with medication</td>
<td valign="top" align="left">Yes</td>
</tr>
<tr>
<td valign="top" align="left">IV</td>
<td valign="top" align="left">Pain not controlled with medication</td>
<td valign="top" align="left">Yes</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec id="s2g"><label>2.7</label><title>Statistical analysis</title>
<p>All analyses were performed using IBM SPSS Statistics 25.0 and R 4.0.3 under a predefined analytical protocol. Descriptive statistics characterized patient demographics, surgical history, and complication profiles, with intergroup comparisons (recurrence vs. non-recurrence) contingent upon distributional properties assessed by Kolmogorov&#x2013;Smirnov tests. Normally distributed continuous variables underwent independent samples t-tests, while non-normal continuous variables and categorical data were analyzed via Mann&#x2013;Whitney U tests or chi-square/Fisher&#x0027;s exact tests respectively. Spearman&#x0027;s rank correlation (<italic>&#x03C1;</italic>) quantified associations between intraoperative balloon pressure metrics and both postoperative hypoaesthesia severity and pain recurrence risk. Cox proportional hazards regression with Schoenfeld residual validation identified independent predictors of complications and recurrence, with hazard ratios (HRs) reported at 95&#x0025; confidence intervals. Statistical significance was defined as two-tailed <italic>P</italic>&#x2009;&#x003C;&#x2009;0.05, with all methodologies conforming to TRIPOD and STROBE reporting guidelines.</p>
</sec>
</sec>
<sec id="s3" sec-type="results"><label>3</label><title>Results</title>
<sec id="s3a"><label>3.1</label><title>Comparison of patient baseline characteristics between normal and recurrence groups</title>
<p>Comparative analysis at 12 months demonstrated significantly higher intraoperative pressures in the non-recurrence cohort (<italic>n</italic>&#x2009;&#x003D;&#x2009;108) versus recurrence cohort (<italic>n</italic>&#x2009;&#x003D;&#x2009;7): full-compression phase (131.0&#x2005;kPa [IQR 129&#x2013;134] vs. 125.0&#x2005;kPa [122&#x2013;128]; <italic>P</italic>&#x2009;&#x003C;&#x2009;0.001), pear-shaping phase (134.0&#x2005;kPa [131&#x2013;138] vs. 126.0&#x2005;kPa [126&#x2013;129]; <italic>P</italic>&#x2009;&#x003D;&#x2009;0.001), and maintenance phase (125.0&#x2005;kPa [123&#x2013;126] vs. 123.0&#x2005;kPa [116&#x2013;123]; <italic>P</italic>&#x2009;&#x003D;&#x2009;0.039). Symptom duration was prolonged in recurrence cases (25.0 months [24.5&#x2013;31.5] vs. 20.0 [13.8&#x2013;25.0]; <italic>P</italic>&#x2009;&#x003D;&#x2009;0.017). No significant intergroup differences (<italic>P</italic>&#x2009;&#x003E;&#x2009;0.05) were observed in BNI hypoaesthesia scores (24&#x2005;h/12mo), sex distribution, age stratification, lesion topography, or trigeminal branch involvement. These findings suggest phase-specific pressure metrics and symptom duration may serve as predictors of recurrence, whereas sensory outcomes and demographic/anatomic factors demonstrate limited prognostic utility (<xref ref-type="table" rid="T3">Table&#x00A0;3</xref>).</p>
<table-wrap id="T3" position="float"><label>Table&#x00A0;3</label>
<caption><p>Comparison of patient baseline characteristics between normal and recurrence groups (12 months).</p></caption>
<table>
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left" rowspan="2">Variable</th>
<th valign="top" align="center">Non-recurrence group</th>
<th valign="top" align="center">Recurrence group</th>
<th valign="top" align="center" rowspan="2"><italic>p</italic>.overall</th>
</tr>
<tr>
<th valign="top" align="center"><italic>N</italic>&#x2009;&#x003D;&#x2009;108</th>
<th valign="top" align="center"><italic>N</italic>&#x2009;&#x003D;&#x2009;7</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">The whole period pressure</td>
<td valign="top" align="center">131 [129;134]</td>
<td valign="top" align="center">125 [122;128]</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Pears shaped period pressure</td>
<td valign="top" align="center">134 [131;138]</td>
<td valign="top" align="center">126 [126;129]</td>
<td valign="top" align="center">0.001</td>
</tr>
<tr>
<td valign="top" align="left">Maintenance period pressure</td>
<td valign="top" align="center">125 [123;126]</td>
<td valign="top" align="center">123 [116;123]</td>
<td valign="top" align="center">0.039</td>
</tr>
<tr>
<td valign="top" align="left">Postoperative numbness score</td>
<td valign="top" align="center" rowspan="2"/>
<td valign="top" align="center" rowspan="2"/>
<td valign="top" align="center" rowspan="2">0.553</td>
</tr>
<tr>
<td valign="top" align="left">(12 month)</td>
</tr>
<tr>
<td valign="top" align="left">1</td>
<td valign="top" align="center">44 (40.7&#x0025;)</td>
<td valign="top" align="center">4 (57.1&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">2</td>
<td valign="top" align="center">61 (56.5&#x0025;)</td>
<td valign="top" align="center">3 (42.9&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">3</td>
<td valign="top" align="center">3 (2.78&#x0025;)</td>
<td valign="top" align="center">0 (0.00&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Gender</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">1</td>
</tr>
<tr>
<td valign="top" align="left">Male</td>
<td valign="top" align="center">44 (40.7&#x0025;)</td>
<td valign="top" align="center">3 (42.9&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Female</td>
<td valign="top" align="center">64 (59.3&#x0025;)</td>
<td valign="top" align="center">4 (57.1&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Age:</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">0.571</td>
</tr>
<tr>
<td valign="top" align="left">&#x2264;65 years</td>
<td valign="top" align="center">15 (13.9&#x0025;)</td>
<td valign="top" align="center">1 (14.3&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">65&#x2013;70 years</td>
<td valign="top" align="center">42 (38.9&#x0025;)</td>
<td valign="top" align="center">4 (57.1&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2265;70 years</td>
<td valign="top" align="center">51 (47.2&#x0025;)</td>
<td valign="top" align="center">2 (28.6&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Lesion location</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">1</td>
</tr>
<tr>
<td valign="top" align="left">Right</td>
<td valign="top" align="center">47 (43.5&#x0025;)</td>
<td valign="top" align="center">3 (42.9&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Left</td>
<td valign="top" align="center">61 (56.5&#x0025;)</td>
<td valign="top" align="center">4 (57.1&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Onset duration</td>
<td valign="top" align="center">20.0 [13.8;25.0]</td>
<td valign="top" align="center">25.0 [24.5;31.5]</td>
<td valign="top" align="center">0.017</td>
</tr>
<tr>
<td valign="top" align="left">Distribution of trigeminal neuralgia</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">0.92</td>
</tr>
<tr>
<td valign="top" align="left">V1</td>
<td valign="top" align="center">2 (1.85&#x0025;)</td>
<td valign="top" align="center">0 (0.00&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">V2</td>
<td valign="top" align="center">19 (17.6&#x0025;)</td>
<td valign="top" align="center">1 (14.3&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">V3</td>
<td valign="top" align="center">30 (27.8&#x0025;)</td>
<td valign="top" align="center">2 (28.6&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">V1&#x2009;&#x002B;&#x2009;V2</td>
<td valign="top" align="center">6 (5.56&#x0025;)</td>
<td valign="top" align="center">0 (0.00&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">V1&#x2009;&#x002B;&#x2009;V3</td>
<td valign="top" align="center">1 (0.93&#x0025;)</td>
<td valign="top" align="center">0 (0.00&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">V2&#x2009;&#x002B;&#x2009;V3</td>
<td valign="top" align="center">37 (34.3&#x0025;)</td>
<td valign="top" align="center">4 (57.1&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">V1&#x2009;&#x002B;&#x2009;V2&#x2009;&#x002B;&#x2009;V3</td>
<td valign="top" align="center">13 (12.0&#x0025;)</td>
<td valign="top" align="center">0 (0.00&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
</tbody>
</table>
</table-wrap>
<p>Comparative assessment at 24 months revealed significantly elevated intraoperative pressures in the non-recurrence cohort (<italic>n</italic>&#x2009;&#x003D;&#x2009;98) versus recurrence group (<italic>n</italic>&#x2009;&#x003D;&#x2009;17) for both full-compression (<italic>P</italic>&#x2009;&#x003C;&#x2009;0.001) and pear-shaping phases (<italic>P</italic>&#x2009;&#x003C;&#x2009;0.001), whereas maintenance phase pressures demonstrated no intergroup difference (<italic>P</italic>&#x2009;&#x003D;&#x2009;0.289). Symptom duration remained prolonged in recurrence cases (<italic>P</italic>&#x2009;&#x003D;&#x2009;0.014). No significant associations were observed between recurrence status and: BNI hypoaesthesia scores at 24&#x2005;h (<italic>P</italic>&#x2009;&#x003D;&#x2009;0.396) or 12mo (<italic>P</italic>&#x2009;&#x003D;&#x2009;0.308) Sex distribution (<italic>P</italic>&#x2009;&#x003E;&#x2009;0.99) Age stratification (<italic>P</italic>&#x2009;&#x003E;&#x2009;0.99) Lesion topography (<italic>P</italic>&#x2009;&#x003D;&#x2009;1.000) Trigeminal branch involvement (<italic>P</italic>&#x2009;&#x003D;&#x2009;1.000). These findings reinforce phase-specific pressure thresholds (full-compression/pear-shaping) and symptom duration as potential predictors of long-term recurrence, contrasting with the limited prognostic utility of sensory outcomes, demographic variables, and anatomical factors (<xref ref-type="table" rid="T4">Table&#x00A0;4</xref>).</p>
<table-wrap id="T4" position="float"><label>Table&#x00A0;4</label>
<caption><p>Comparison of patient baseline characteristics between normal and recurrence groups (24 months).</p></caption>
<table>
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left" rowspan="2">Variable</th>
<th valign="top" align="center">Non-recurrence group</th>
<th valign="top" align="center">Recurrence group</th>
<th valign="top" align="center"><italic>p</italic>.overall</th>
</tr>
<tr>
<th valign="top" align="center"><italic>N</italic>&#x2009;&#x003D;&#x2009;98</th>
<th valign="top" align="center"><italic>N</italic>&#x2009;&#x003D;&#x2009;17</th>
<th valign="top" align="center"/>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">The whole period pressure</td>
<td valign="top" align="center">131 [129;134]</td>
<td valign="top" align="center">128 [125;131]</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Pears shaped period pressure</td>
<td valign="top" align="center">134 [131;138]</td>
<td valign="top" align="center">128 [126;131]</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Maintenance period pressure</td>
<td valign="top" align="center">124 [123;126]</td>
<td valign="top" align="center">124 [121;126]</td>
<td valign="top" align="center">0.289</td>
</tr>
<tr>
<td valign="top" align="left">X24 month postoperative numbness score</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">0.308</td>
</tr>
<tr>
<td valign="top" align="left">1</td>
<td valign="top" align="center">38 (38.8&#x0025;)</td>
<td valign="top" align="center">10 (58.8&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">2</td>
<td valign="top" align="center">57 (58.2&#x0025;)</td>
<td valign="top" align="center">7 (41.2&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">3</td>
<td valign="top" align="center">3 (3.06&#x0025;)</td>
<td valign="top" align="center">0 (0.00&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Gender</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">1</td>
</tr>
<tr>
<td valign="top" align="left">Male</td>
<td valign="top" align="center">40 (40.8&#x0025;)</td>
<td valign="top" align="center">7 (41.2&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Female</td>
<td valign="top" align="center">58 (59.2&#x0025;)</td>
<td valign="top" align="center">10 (58.8&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Age</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">1</td>
</tr>
<tr>
<td valign="top" align="left">&#x2264;65years</td>
<td valign="top" align="center">14 (14.3&#x0025;)</td>
<td valign="top" align="center">2 (11.8&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">60&#x2013;70years</td>
<td valign="top" align="center">39 (39.8&#x0025;)</td>
<td valign="top" align="center">7 (41.2&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2265;70 years</td>
<td valign="top" align="center">45 (45.9&#x0025;)</td>
<td valign="top" align="center">8 (47.1&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Lesion location</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">1</td>
</tr>
<tr>
<td valign="top" align="left">Right</td>
<td valign="top" align="center">43 (43.9&#x0025;)</td>
<td valign="top" align="center">7 (41.2&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Left</td>
<td valign="top" align="center">55 (56.1&#x0025;)</td>
<td valign="top" align="center">10 (58.8&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Onset duration</td>
<td valign="top" align="center">19.0 [13.0;24.0]</td>
<td valign="top" align="center">25.0 [23.0;28.0]</td>
<td valign="top" align="center">0.014</td>
</tr>
<tr>
<td valign="top" align="left">Distribution of trigeminal neuralgia</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">0.99</td>
</tr>
<tr>
<td valign="top" align="left">V1</td>
<td valign="top" align="center">2 (2.04&#x0025;)</td>
<td valign="top" align="center">0 (0.00&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">V2</td>
<td valign="top" align="center">17 (17.3&#x0025;)</td>
<td valign="top" align="center">3 (17.6&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">V3</td>
<td valign="top" align="center">27 (27.6&#x0025;)</td>
<td valign="top" align="center">5 (29.4&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">V1&#x2009;&#x002B;&#x2009;V2</td>
<td valign="top" align="center">5 (5.10&#x0025;)</td>
<td valign="top" align="center">1 (5.88&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">V1&#x2009;&#x002B;&#x2009;V3</td>
<td valign="top" align="center">1 (1.02&#x0025;)</td>
<td valign="top" align="center">0 (0.00&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">V2&#x2009;&#x002B;&#x2009;V3</td>
<td valign="top" align="center">34 (34.7&#x0025;)</td>
<td valign="top" align="center">7 (41.2&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">V1&#x2009;&#x002B;&#x2009;V2&#x2009;&#x003D;&#x2009;V3</td>
<td valign="top" align="center">12 (12.2&#x0025;)</td>
<td valign="top" align="center">1 (5.88&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3b"><label>3.2</label><title>Balloon pressure dynamics in case ID 001</title>
<p>Intraoperative monitoring revealed a distinct biphasic profile: the pear-shaping phase (0&#x2013;109.0&#x2005;s) transitioned to the maintenance phase (109.0&#x2013;150.0&#x2005;s) following abrupt pressure decay (&#x003E;15&#x0025;/5&#x2005;s). Therapeutic pressure was restored via contrast boluses (0.1&#x2013;0.2&#x2005;mL), eliciting rapid recovery (<italic>&#x0394;</italic>&#x2009;&#x003E;&#x2009;30&#x2005;kPa within 1&#x2005;s) followed by gradual decline (slope: &#x2212;0.8&#x2005;kPa/s). As illustrated in <xref ref-type="fig" rid="F5">Figure&#x00A0;5A</xref>, key inflection points included: initial inflation peak (P1: 175&#x2005;kPa), early decay plateau (P2: 142&#x2013;155&#x2005;kPa), phase transition threshold (P3: 125&#x2005;kPa), and maintenance band (P4: 110&#x2013;130&#x2005;kPa) (<xref ref-type="fig" rid="F5">Figure&#x00A0;5</xref>).</p>
<fig id="F5" position="float"><label>Figure&#x00A0;5</label>
<caption><p>Balloon pressure dynamics in case ID 001.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fsurg-13-1651583-g005.tif"><alt-text content-type="machine-generated">Graph displaying balloon pressure in kilopascals (kPa) against compression time in seconds. Pressure starts at 180 kPa, decreases sharply to 120 kPa, then fluctuates slightly. Key points P1 to P4 are marked.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3c"><label>3.3</label><title>Pressure reference intervals</title>
<p>Phase-specific reference intervals were established per CLSI EP28-A3c guidelines: Pear-shaping phase (<italic>n</italic>&#x2009;&#x003D;&#x2009;10,641 measurements):125.7&#x2013;157.6&#x2005;kPa Maintenance phase (<italic>n</italic>&#x2009;&#x003D;&#x2009;4,059 measurements):116.0&#x2013;134.4&#x2005;kPa Full-compression phase (<italic>n</italic>&#x2009;&#x003D;&#x2009;14,700 measurements):118.9&#x2013;146.3&#x2005;kPa These evidence-based thresholds provide quantitative benchmarks for intraoperative balloon pressure regulation during percutaneous trigeminal ganglion compression (<xref ref-type="table" rid="T5">Table&#x00A0;5</xref>).</p>
<table-wrap id="T5" position="float"><label>Table&#x00A0;5</label>
<caption><p>Pressure reference intervals.</p></caption>
<table>
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Variable</th>
<th valign="top" align="center">Pear-shaped stage</th>
<th valign="top" align="center">Maintenance pase</th>
<th valign="top" align="center">Whole course phase</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Observed values</td>
<td valign="top" align="center">10,641</td>
<td valign="top" align="center">4,059</td>
<td valign="top" align="center">14,700</td>
</tr>
<tr>
<td valign="top" align="left">Reference intervals</td>
<td valign="top" align="center">157.6&#x223C;125.7</td>
<td valign="top" align="center">134.4&#x223C;116.0</td>
<td valign="top" align="center">146.3&#x223C;118.9</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3d"><label>3.4</label><title>Analysis of the correlation between balloon pressure in different postoperative stages and facial complications</title>
<p>The analysis revealed a significant positive correlation between the number of trigeminal neuralgia recurrences at 12 months (num12&#x2005;m) and at 24 months (num24r) (r&#x2009;&#x003D;&#x2009;0.65), indicating a persistent pattern of recurrence over time. The overall recurrence rate (Whole) also showed a high positive correlation with the recurrence rates at both 12 months (r&#x2009;&#x003D;&#x2009;0.39) and 24 months (r&#x2009;&#x003D;&#x2009;0.62), further confirming the consistency of the condition&#x0027;s impact. Furthermore, we assessed the relationship between paresthesia at different time points and the recurrence rate. We found that paresthesia experienced 24&#x2005;h prior (Pr24) and paresthesia experienced 12 months prior (Pr12) both had some correlation with the recurrence rate, which may suggest that paresthesia is a predictive factor for the recurrence of trigeminal neuralgia. Notably, the slight negative correlation between paresthesia experienced 12 months prior (Pr12) and the laterality of the lesion (Location) (r&#x2009;&#x003D;&#x2009;&#x2212;0.08) might reflect the impact of lesion location on the experience of paresthesia. During the maintenance phase, we observed a moderate positive correlation with the recurrence rates at 12 months (r&#x2009;&#x003D;&#x2009;0.05) and 24 months (r&#x2009;&#x003D;&#x2009;0.13), which could imply a potential role for maintenance therapy in controlling the recurrence of the condition, although the correlation is not strong. No significant correlation was found between the distribution of recurrence rates and other variables, indicating a relatively uniform distribution of recurrences across different subgroups. In summary, our findings reveal patterns of trigeminal neuralgia recurrence and its relationship with paresthesia, providing a new perspective for understanding the long-term management and treatment of this complex condition. These insights could potentially influence the development of clinical treatment strategies, especially in considering how maintenance therapy might be used to reduce recurrences and improve patients&#x0027; quality of life (<xref ref-type="fig" rid="F6">Figure&#x00A0;6</xref>).</p>
<fig id="F6" position="float"><label>Figure&#x00A0;6</label>
<caption><p>Analysis of the correlation between balloon pressure in different postoperative stages and facial complications.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fsurg-13-1651583-g006.tif"><alt-text content-type="machine-generated">A correlation matrix visualizes the relationships between variables like num12m, num24r, Pears, Whole, Maintenance, Distribution, Age, Onset, Location, Pr24, Pr12, and Gender. It uses blue and red circles to indicate positive and negative correlations, respectively, with varying sizes representing correlation strength. The color gradient from blue to red corresponds to a scale from -1 to 1. Annotations on the right define each variable's meaning, such as recurrence of trigeminal neuralgia and pressure levels.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3e"><label>3.5</label><title>The non-recurrence curve of patients (grouped by sex and age)</title>
<p>We constructed the Kaplan&#x2013;Meier curves of postoperative pain recurrence using time to postoperative pain recurrence as the horizontal axis and postoperative non-recurrence rate as the vertical axis. The curves were grouped by gender and age group. The risk table illustrated the precise number of individuals at risk of postoperative pain recurrence with increasing postoperative time. The Kaplan&#x2013;Meier curves indicated that the recurrence rate was higher in men than in women in the younger below 60 years (<xref ref-type="fig" rid="F7">Figure&#x00A0;7A</xref>) and older above 70 years (<xref ref-type="fig" rid="F7">Figure&#x00A0;7C</xref>) age groups. Conversely, the recurrence rate was higher in women than in men in the intermediate age group 60&#x2013;70 years (<xref ref-type="fig" rid="F7">Figure&#x00A0;7B</xref>). However, this difference was not statistically significant.</p>
<fig id="F7" position="float"><label>Figure&#x00A0;7</label>
<caption><p>Kaplan-Meier survival curves showing non-recurrence probability by sex across different age groups. <bold>(A)</bold> Patients &#x003C;60 years. <bold>(B)</bold> Patients 60&#x2013;70 years. <bold>(C)</bold> Patients &#x2265;70 years.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fsurg-13-1651583-g007.tif"><alt-text content-type="machine-generated">Kaplan-Meier survival curves for non-recurrence probability over 24 months, segmented by age and gender. Panel A compares males and females under 60, with males showing lower non-recurrence. Panel B compares males and females aged 60 to 70, showing more similar curves. Panel C compares individuals aged 70 and older, with slightly better non-recurrence for males. Each panel includes a \"number at risk\" table.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion"><label>4</label><title>Discussion</title>
<p>Since its first report in 1983, PBC has been refined and is now an effective minimally invasive treatment for TN (<xref ref-type="bibr" rid="B19">19</xref>). By mechanically damaging the trigeminal nerve&#x0027;s sensory fibers, it alleviates pain. Surgical factors like balloon shape, compression time, and pressure significantly affect outcomes (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B20">20</xref>). Our study highlights that compression time and pressure are especially critical. Intraoperative lateral X - ray fluoroscopy showing a balloon in a &#x201C;pear - shaped&#x201D; form is the gold standard for confirming accurate placement in Meckel&#x0027;s cavity (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B21">21</xref>). All patients in this study met this standard, with 99.1&#x0025; achieving pain relief, indicating a highly effective procedure. A 150 - second compression time ensures efficacy while preventing significant facial numbness - related quality - of - life impacts. We assessed facial numbness at various postoperative time points. At 24&#x2005;h post - surgery, among 115 pain - relieved patients, there were 19, 63, 33, and 0 patients with Grade &#x2163;, &#x2162;, &#x2161;, and &#x2160; facial numbness, respectively. At 12 months, these numbers were 0, 3, 64, and 48. The proportion of Grade &#x2163; facial numbness at 24&#x2005;h was 16.52&#x0025;, but at 12 months, Grade &#x2160; and &#x2161; cases accounted for 97.3&#x0025;, with only 3 patients having Grade &#x2162; or higher facial numbness. This shows that facial numbness decreases over time with minimal impact on patients&#x2019; lives, aligning with prior studies that PBC is effective and has few complications when compression time is within 1&#x2013;3&#x2005;min. After recognizing the importance of balloon shape and compression time in PBC surgery, we delved deeper into how balloon pressure affects treatment and post - operative complications.</p>
<p>Our study found that balloon pressure during the pear - shaped, holding, and entire periods is closely linked to the incidence and severity of facial numbness - the higher the pressure, the higher the numbness grade. Looking at 19 patients with Grade &#x2162; or higher facial numbness at 24&#x2005;h post - surgery, we found their initial pear - shaped phase pressure all exceeded 170&#x2005;kPa. This shows controlling pressure during this phase is key as excessive initial pressure can lead to severe facial numbness, so initial pear - shaped phase pressure should be limited. Also, balloon pressure is negatively related to pain recurrence risk - the lower the pressure, the higher the risk. In our study, the 3 recurrence cases had a history of multiple prior surgeries at other hospitals and their initial balloon pressure was all below 141&#x2005;kPa. We guess severe Meckel&#x0027;s cavity adhesions might reduce the lesion effect at low pressure, so properly increasing pressure during the holding phase may enhance therapeutic effect. Moreover, the lesion side and patient age showed no significant link to post - operative outcomes. This indicates that, when the balloon takes a &#x201C;pear shape&#x201D;, pressure and time are key factors in determining the extent of trigeminal ganglion damage. Other studies have similar findings. Zanusso et al. (<xref ref-type="bibr" rid="B22">22</xref>) in a study of 22 patients, found under the same compression time (3.5&#x2005;min), the low - pressure (0.9&#x2013;1.3 Bar) group had a 75&#x0025; recurrence rate but no complications, while the high - pressure (1.9&#x2013;2.4 Bar) group had no recurrences but more complications. Brown and Pilitsis&#x0027; (<xref ref-type="bibr" rid="B15">15</xref>) research shows 1.5 - minute balloon compression at 1,140&#x2013;1,215&#x2005;mmHg pressure reduces complications like masseter weakness but doesn&#x0027;t affect pain or recurrence rates. Peng et al. (<xref ref-type="bibr" rid="B23">23</xref>) followed up with 45 patients for 3 months and found that intraoperative BP of 138.65&#x2013;153.90&#x2005;KPa can effectively relieve pain and reduce complications. So, balloon pressure is a key factor affecting PBC&#x0027;s efficacy and complications. Optimizing pressure control is of great importance for improving surgical outcomes and lowering recurrence and complication risks.</p>
<p>When exploring the factors affecting the post - operative outcome of percutaneous balloon compression (PBC), balloon pressure control is a vital part. Past studies indicate that intra - operative balloon pressure in PBC usually ranges from 60 to 170&#x2005;kPa (<xref ref-type="bibr" rid="B24">24</xref>), 138.65 to 153.90&#x2005;kPa (<xref ref-type="bibr" rid="B23">23</xref>), and 130 to 200&#x2005;kPa (<xref ref-type="bibr" rid="B25">25</xref>). But these studies have limitations in guiding clinical practice. On the one hand, they fail to finely divide the surgical process based on the dynamic intra - operative intracystic pressure changes. On the other hand, the lack of continuous monitoring and real - time regulation of balloon pressure reduces the accuracy of pressure control, possibly affecting the stability and reproducibility of the surgical outcome. In this study, a real - time pressure monitoring system was innovatively introduced during PBC. By connecting a pressure transducer to a computer, balloon pressure changes were continuously recorded at a frequency of once per second. This provided crucial evidence for precise intra - operative balloon pressure regulation. Post - operatively, the research team rigorously analyzed the collected data, eliminating data from patients with unrelieved pain and recurrences that could cause interference. Then, following the robust assessment method recommended in the CLSI C28 - A2 document, reference ranges for balloon pressure in the pear - shaped phase, maintenance phase, and entire phase were determined as 126.5&#x2013;156.8&#x2005;kPa, 117.9&#x2013;136.1&#x2005;kPa, and 119.9&#x2013;141.9&#x2005;kPa, respectively. This staging and pressure control method based on real - time monitoring data helps surgeons precisely regulate balloon pressure during operations. It also effectively balances the risks of post - operative pain relief and complications, thus comprehensively optimizing patients&#x0027; treatment outcomes and maximizing their benefits. Surgeons can more intuitively understand the dynamic changes in balloon pressure during surgery and adjust pressure parameters according to individual patients&#x2019; specific conditions. Moreover, robotic-assisted technology in peripheral nerve microsurgery provides an instructive paradigm for standardizing PBC. Research by Jiang et al. (<xref ref-type="bibr" rid="B26">26</xref>) demonstrated that in limb and cervicothoracic regions lacking natural anatomical spaces, the use of a robotic platform to create an artificial pneumocavity with integrated real-time pressure-visual feedback can reduce microsurgical error to sub-millimeter levels, limit incision length to less than 1&#x2005;cm, and significantly lower perioperative complications such as nerve adhesion and scar-related pain. As early as 2016, the same team utilized the da Vinci system to establish an anterior cervical working cavity through bilateral 4-cm supraclavicular incisions and successfully performed contralateral C7-to-ipsilateral C7 nerve transfer in a cadaveric model (<xref ref-type="bibr" rid="B27">27</xref>).</p>
<p>The involvement of such advanced technology not only reduces surgical difficulty and operational risks but also minimizes tissue trauma and associated complications. The insight from Jiang et al. suggests that by enabling continuous digital monitoring of key intraoperative parameters&#x2014;pressure, time, and spatial localization&#x2014;procedures traditionally reliant on the surgeon&#x0027;s subjective &#x201C;feel&#x201D; can be transformed into repeatable, quality-controllable standardized workflows. Similarly, in PBC, real-time coupling of the &#x201C;pear-shaped&#x201D; configuration judgment with the balloon pressure-time curve, along with software-defined safety thresholds and alarms, could&#x2014;much like the role played by the da Vinci platform in peripheral nerve surgery&#x2014;elevate the principle of &#x201C;sufficient yet not excessive&#x201D; nerve ablation from an operator-dependent art to an algorithm-guided process. This shift would advance PBC from an experience-based practice toward precision medicine. Therefore, real-time balloon pressure monitoring is not only feasible but should be adopted as a routine component of PBC. Its potential contribution to surgical quality control parallels the successful paradigm established by robot-assisted minimally invasive techniques in the field of peripheral nerve surgery.</p>
</sec>
<sec id="s5"><label>5</label><title>Limitation</title>
<p>Our single-center observational study has limitations that necessitate cautious interpretation. With a sample size of 115 patients and a maximum follow-up of 24 months, we may not fully capture long-term complications or recurrence trends. The observational design limits establishing a causal link between pressure parameters and outcomes, and we did not systematically collect all potential anatomical and pathological variables, which may affect the accuracy of our correlations. The accuracy of intraoperative pressure measurements is constrained by equipment resolution and may not fully capture pressure dynamics. Our inclusion criterion of a successful &#x201C;pear shape&#x201D; formation during the procedure means our findings apply mainly to this subgroup, with unknown differences in outcomes for those without this shape. Some outcome measures, like facial numbness, are subjective and may introduce bias. The single-center design may not reflect variations in surgical techniques across different centers, affecting the generalizability of our results. To overcome these limitations, we are initiating a prospective, multi-center study with at least 300 patients to collect detailed data and use advanced analytical methods to build a robust predictive model and better understand the relationship between pressure dynamics and clinical outcomes.</p>
</sec>
<sec id="s6" sec-type="conclusions"><label>6</label><title>Conclusion</title>
<p>During PBC for trigeminal neuralgia, balloon pressure control is critical. We found that balloon pressure during the pear - shaped, holding, and entire periods is closely related to postoperative complications and recurrence. High pressure worsens facial numbness, and low pressure causes pain recurrence. The study gives reference ranges for balloon pressure in each stage: 126.5&#x2013;156.8&#x2005;kPa (pear - shaped), 117.9&#x2013;136.1&#x2005;kPa (holding), and 119.9&#x2013;141.9&#x2005;kPa (entire period). These offer a quantitative basis for intraoperative pressure control, helping optimise treatment and reduce complications. Also, the study highlights the value of real - time balloon pressure monitoring, which boosts the stability and reproducibility of the surgery, thus promoting the standardized and personalized development of PBC.</p>
</sec>
</body>
<back>
<sec id="s7" sec-type="data-availability"><title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s8" sec-type="ethics-statement"><title>Ethics statement</title>
<p>The studies involving humans were approved by the Ethics Committee of Gansu Provincial People&#x0027;s Hospital (Approval number: 2022-072). The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants&#x0027; legal guardians/next of kin. Written informed consent was obtained from the individual(s), and minor(s)&#x0027; legal guardian/next of kin, for the publication of any potentially identifiable images or data included in this article.</p>
</sec>
<sec id="s9" sec-type="author-contributions"><title>Author contributions</title>
<p>FW: Data curation, Formal analysis, Writing &#x2013; original draft. KG: Methodology, Validation, Visualization, Writing &#x2013; original draft. QS: Data curation, Investigation, Resources, Writing &#x2013; review &#x0026; editing. JZ: Conceptualization, Funding acquisition, Supervision, Writing &#x2013; review &#x0026; editing. BY: Data curation, Investigation, Resources, Writing &#x2013; original draft. SP: Conceptualization, Funding acquisition, Software, Supervision, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<ack><title>Acknowledgments</title>
<p>The authors express their sincere gratitude to all participants involved in this study.</p>
</ack>
<sec id="s11" sec-type="COI-statement"><title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s12" sec-type="ai-statement"><title>Generative AI statement</title>
<p>The author(s) declared that generative AI was used in the creation of this manuscript. The authors declare that Gen AI was used in the native - English - speaker language polishing of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="s13" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashina</surname> <given-names>S</given-names></name> <name><surname>Robertson</surname> <given-names>CE</given-names></name> <name><surname>Srikiatkhachorn</surname> <given-names>A</given-names></name> <name><surname>Stefano</surname> <given-names>GD</given-names></name> <name><surname>Donnet</surname> <given-names>A</given-names></name> <name><surname>Hodaie</surname> <given-names>M</given-names></name><etal/></person-group> <article-title>Trigeminal neuralgia</article-title>. <source>Nat Rev Dis Primers</source>. (<year>2024</year>) <volume>10</volume>:<fpage>39</fpage>. <pub-id pub-id-type="doi">10.1038/s41572-024-00523-z</pub-id><pub-id pub-id-type="pmid">38816415</pub-id></mixed-citation></ref>
<ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullan</surname> <given-names>S</given-names></name> <name><surname>Lichtor</surname> <given-names>T</given-names></name></person-group>. <article-title>Percutaneous microcompression of the trigeminal ganglion for trigeminal neuralgia</article-title>. <source>J Neurosurg</source>. (<year>1983</year>) <volume>59</volume>:<fpage>1007</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.3171/jns.1983.59.6.1007</pub-id><pub-id pub-id-type="pmid">6631493</pub-id></mixed-citation></ref>
<ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darrow</surname> <given-names>DP</given-names></name> <name><surname>Haines</surname> <given-names>SJ</given-names></name> <name><surname>Grande</surname> <given-names>AW</given-names></name></person-group>. <article-title>Letter to the editor. Modern percutaneous balloon compression for trigeminal neuralgia</article-title>. <source>J Neurosurg</source>. (<year>2023</year>) <volume>139</volume>:<fpage>923</fpage>. <pub-id pub-id-type="doi">10.3171/2023.1.JNS2382</pub-id><pub-id pub-id-type="pmid">37209080</pub-id></mixed-citation></ref>
<ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willsey</surname> <given-names>MS</given-names></name> <name><surname>Mossner</surname> <given-names>JM</given-names></name> <name><surname>Chestek</surname> <given-names>CA</given-names></name> <name><surname>Sagher</surname> <given-names>O</given-names></name> <name><surname>Patil</surname> <given-names>PG</given-names></name></person-group>. <article-title>Classifier using pontine radial diffusivity and symptom duration accurately predicts recurrence of trigeminal neuralgia after microvascular decompression: a pilot study and algorithm description</article-title>. <source>Neurosurgery</source>. (<year>2021</year>) <volume>89</volume>:<fpage>777</fpage>&#x2013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1093/neuros/nyab292</pub-id><pub-id pub-id-type="pmid">34383939</pub-id></mixed-citation></ref>
<ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McBenedict</surname> <given-names>B</given-names></name> <name><surname>Hauwanga</surname> <given-names>WN</given-names></name> <name><surname>Yau</surname> <given-names>MCY</given-names></name> <name><surname>Pogodina</surname> <given-names>A</given-names></name> <name><surname>Singh</surname> <given-names>G</given-names></name> <name><surname>Abdelrahman</surname> <given-names>A</given-names></name><etal/></person-group> <article-title>Outcomes of different surgical interventions for treating trigeminal neuralgia: a review</article-title>. <source>Cureus</source>. (<year>2024</year>) <volume>16</volume>:<fpage>e66724</fpage>. <pub-id pub-id-type="doi">10.7759/cureus.66724</pub-id><pub-id pub-id-type="pmid">39262536</pub-id></mixed-citation></ref>
<ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asplund</surname> <given-names>P</given-names></name> <name><surname>Linderoth</surname> <given-names>B</given-names></name> <name><surname>Lind</surname> <given-names>G</given-names></name> <name><surname>Winter</surname> <given-names>J</given-names></name> <name><surname>Bergenheim</surname> <given-names>AT</given-names></name></person-group>. <article-title>One hundred eleven percutaneous balloon compressions for trigeminal neuralgia in a cohort of 66 patients with multiple sclerosis</article-title>. <source>Oper Neurosurg (Hagerstown)</source>. (<year>2019</year>) <volume>17</volume>:<fpage>452</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/ons/opy402</pub-id></mixed-citation></ref>
<ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname> <given-names>W</given-names></name> <name><surname>Hu</surname> <given-names>W</given-names></name> <name><surname>Chi</surname> <given-names>L</given-names></name> <name><surname>Zhang</surname> <given-names>L</given-names></name></person-group>. <article-title>Factors that may affect recurrence of trigeminal neuralgia after percutaneous balloon compression</article-title>. <source>J Clin Neurosci</source>. (<year>2022</year>) <volume>99</volume>:<fpage>248</fpage>&#x2013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/j.jocn.2022.03.022</pub-id><pub-id pub-id-type="pmid">35305467</pub-id></mixed-citation></ref>
<ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kourilsky</surname> <given-names>A</given-names></name> <name><surname>Palpacuer</surname> <given-names>C</given-names></name> <name><surname>Rogers</surname> <given-names>A</given-names></name> <name><surname>Chauvet</surname> <given-names>D</given-names></name> <name><surname>Wiart</surname> <given-names>C</given-names></name> <name><surname>Bourdillon</surname> <given-names>P</given-names></name><etal/></person-group> <article-title>Multivariate models to predict pain recurrence and sensitive complications after percutaneous balloon compression in trigeminal neuralgia</article-title>. <source>J Neurosurg</source>. (<year>2022</year>) <volume>137</volume>:<fpage>1396</fpage>&#x2013;<lpage>405</lpage>. <pub-id pub-id-type="doi">10.3171/2022.2.JNS212644</pub-id><pub-id pub-id-type="pmid">35453109</pub-id></mixed-citation></ref>
<ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>C</given-names></name> <name><surname>Zheng</surname> <given-names>W</given-names></name> <name><surname>Zhu</surname> <given-names>Q</given-names></name> <name><surname>Du</surname> <given-names>Q</given-names></name> <name><surname>Yu</surname> <given-names>W</given-names></name></person-group>. <article-title>The transformation of the balloon shape in percutaneous balloon compression for trigeminal neuralgia</article-title>. <source>J Pain Res</source>. (<year>2021</year>) <volume>14</volume>:<fpage>3805</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.2147/JPR.S343783</pub-id><pub-id pub-id-type="pmid">34934354</pub-id></mixed-citation></ref>
<ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiaochuan</surname> <given-names>H</given-names></name> <name><surname>Xiaoyun</surname> <given-names>S</given-names></name> <name><surname>Junsheng</surname> <given-names>L</given-names></name> <name><surname>Ning</surname> <given-names>G</given-names></name> <name><surname>Wenshi</surname> <given-names>G</given-names></name> <name><surname>Zhenxing</surname> <given-names>Z</given-names></name></person-group>. <article-title>Percutaneous microballoon compression for trigeminal neuralgia using dyna-CT</article-title>. <source>Interv Neuroradiol</source>. (<year>2013</year>) <volume>19</volume>:<fpage>359</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1177/159101991301900314</pub-id><pub-id pub-id-type="pmid">24070086</pub-id></mixed-citation></ref>
<ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>W</given-names></name> <name><surname>Jiang</surname> <given-names>C</given-names></name> <name><surname>Yu</surname> <given-names>C</given-names></name> <name><surname>Liang</surname> <given-names>W</given-names></name></person-group>. <article-title>Percutaneous balloon compression for persistent or recurrent trigeminal neuralgia after microvascular decompression: personal experience of 28 patients</article-title>. <source>Acta Neurol Belg</source>. (<year>2018</year>) <volume>118</volume>:<fpage>561</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1007/s13760-017-0858-8</pub-id><pub-id pub-id-type="pmid">29110188</pub-id></mixed-citation></ref>
<ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>B</given-names></name> <name><surname>Mei</surname> <given-names>J</given-names></name></person-group>. <article-title>Percutaneous balloon compression guided by a compression-time effect in trigeminal nerve branches</article-title>. <source>J Craniofac Surg</source>. (<year>2024</year>) <volume>35</volume>(<issue>8</issue>):<fpage>4</fpage>. <pub-id pub-id-type="doi">10.1097/SCS.0000000000010497</pub-id></mixed-citation></ref>
<ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>F</given-names></name> <name><surname>Han</surname> <given-names>S</given-names></name> <name><surname>Ma</surname> <given-names>Y</given-names></name> <name><surname>Yi</surname> <given-names>F</given-names></name> <name><surname>Xu</surname> <given-names>X</given-names></name> <name><surname>Liu</surname> <given-names>Y</given-names></name></person-group>. <article-title>Optimal duration of percutaneous microballoon compression for treatment of trigeminal nerve injury</article-title>. <source>Neural Regen Res</source>. (<year>2014</year>) <volume>9</volume>:<fpage>179</fpage>&#x2013;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.4103/1673-5374.125347</pub-id><pub-id pub-id-type="pmid">25206799</pub-id></mixed-citation></ref>
<ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skirving</surname> <given-names>DJ</given-names></name> <name><surname>Dan</surname> <given-names>NG</given-names></name></person-group>. <article-title>A 20-year review of percutaneous balloon compression of the trigeminal ganglion</article-title>. <source>J Neurosurg</source>. (<year>2001</year>) <volume>94</volume>:<fpage>913</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.3171/jns.2001.94.6.0913</pub-id><pub-id pub-id-type="pmid">11409519</pub-id></mixed-citation></ref>
<ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname> <given-names>JA</given-names></name> <name><surname>Pilitsis</surname> <given-names>JG</given-names></name></person-group>. <article-title>Percutaneous balloon compression for the treatment of trigeminal neuralgia: results in 56 patients based on balloon compression pressure monitoring</article-title>. <source>Neurosurg Focus</source>. (<year>2005</year>) <volume>18</volume>:<fpage>E10</fpage>. <pub-id pub-id-type="doi">10.3171/foc.2005.18.5.11</pub-id><pub-id pub-id-type="pmid">15913277</pub-id></mixed-citation></ref>
<ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Q</given-names></name> <name><surname>Chen</surname> <given-names>C</given-names></name> <name><surname>Guo</surname> <given-names>G</given-names></name> <name><surname>Li</surname> <given-names>Z</given-names></name> <name><surname>Huang</surname> <given-names>D</given-names></name> <name><surname>Zhou</surname> <given-names>H</given-names></name></person-group>. <article-title>A prospective study to examine the association of the foramen Ovale size with intraluminal pressure of pear-shaped balloon in percutaneous balloon compression for trigeminal neuralgia</article-title>. <source>Pain Ther</source>. (<year>2021</year>) <volume>10</volume>:<fpage>1439</fpage>&#x2013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1007/s40122-021-00311-7</pub-id><pub-id pub-id-type="pmid">34460076</pub-id></mixed-citation></ref>
<ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>YQ</given-names></name> <name><surname>He</surname> <given-names>S</given-names></name> <name><surname>Shen</surname> <given-names>YX</given-names></name> <name><surname>Qian</surname> <given-names>C</given-names></name></person-group>. <article-title>Clinical value of a self-designed training model for pinpointing and puncturing trigeminal ganglion</article-title>. <source>Br J Neurosurg</source>. (<year>2014</year>) <volume>28</volume>:<fpage>267</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3109/02688697.2013.835379</pub-id><pub-id pub-id-type="pmid">24628215</pub-id></mixed-citation></ref>
<ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kick</surname> <given-names>SA</given-names></name> <name><surname>Sonntag</surname> <given-names>VK</given-names></name> <name><surname>Spetzler</surname> <given-names>RF</given-names></name></person-group>. <article-title>Neurosurgery at the barrow neurological institute</article-title>. <source>Neurosurgery</source>. (<year>1997</year>) <volume>41</volume>:<fpage>930</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1097/00006123-199710000-00030</pub-id><pub-id pub-id-type="pmid">9316056</pub-id></mixed-citation></ref>
<ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sterman-Neto</surname> <given-names>H</given-names></name> <name><surname>Fukuda</surname> <given-names>CY</given-names></name> <name><surname>Duarte</surname> <given-names>KP</given-names></name> <name><surname>Aparecida da Silva</surname> <given-names>V</given-names></name> <name><surname>Rodrigues</surname> <given-names>ALL</given-names></name> <name><surname>Galhardoni</surname> <given-names>R</given-names></name><etal/></person-group> <article-title>Balloon compression vs radiofrequency for primary trigeminal neuralgia: a randomized, controlled trial</article-title>. <source>Pain</source>. (<year>2021</year>) <volume>162</volume>:<fpage>919</fpage>&#x2013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1097/j.pain.0000000000002070</pub-id><pub-id pub-id-type="pmid">32947541</pub-id></mixed-citation></ref>
<ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>MW</given-names></name> <name><surname>Jiang</surname> <given-names>XF</given-names></name> <name><surname>Niu</surname> <given-names>CS</given-names></name></person-group>. <article-title>Efficacy of and risk factors for percutaneous balloon compression for trigeminal neuralgia in elderly patients</article-title>. <source>Br J Neurosurg</source>. (<year>2021</year>) <volume>35</volume>:<fpage>280</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1080/02688697.2020.1787341</pub-id><pub-id pub-id-type="pmid">32619112</pub-id></mixed-citation></ref>
<ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname> <given-names>Y</given-names></name> <name><surname>Yu</surname> <given-names>G</given-names></name> <name><surname>Min</surname> <given-names>F</given-names></name> <name><surname>Xiang</surname> <given-names>H</given-names></name> <name><surname>Huang</surname> <given-names>J</given-names></name> <name><surname>Leng</surname> <given-names>J</given-names></name></person-group>. <article-title>The focus and new progress of percutaneous balloon compression for the treatment of trigeminal neuralgia</article-title>. <source>J Pain Res</source>. (<year>2022</year>) <volume>15</volume>:<fpage>3059</fpage>&#x2013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.2147/JPR.S374433</pub-id><pub-id pub-id-type="pmid">36199499</pub-id></mixed-citation></ref>
<ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zanusso</surname> <given-names>M</given-names></name> <name><surname>Curri</surname> <given-names>D</given-names></name> <name><surname>Landi</surname> <given-names>A</given-names></name> <name><surname>Colombo</surname> <given-names>F</given-names></name> <name><surname>Volpin</surname> <given-names>L</given-names></name> <name><surname>Cervellini</surname> <given-names>P</given-names></name></person-group>. <article-title>Pressure monitoring inside meckel&#x2019;s cave during percutaneous microcompression of gasserian ganglion</article-title>. <source>Stereotact Funct Neurosurg</source>. (<year>1991</year>) <volume>56</volume>:<fpage>37</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1159/000099391</pub-id><pub-id pub-id-type="pmid">1947500</pub-id></mixed-citation></ref>
<ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname> <given-names>Y</given-names></name> <name><surname>Zou</surname> <given-names>C</given-names></name> <name><surname>Li</surname> <given-names>Y</given-names></name> <name><surname>Li</surname> <given-names>Q</given-names></name> <name><surname>Long</surname> <given-names>H</given-names></name> <name><surname>Yang</surname> <given-names>W</given-names></name><etal/></person-group> <article-title>Balloon pressure and clinical effectiveness of percutaneous microballoon compression in the treatment of primary trigeminal neuralgia</article-title>. <source>Pain Physician</source>. (<year>2024</year>) <volume>27</volume>:<fpage>E345</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.36076/ppj.2024.7.E345</pub-id><pub-id pub-id-type="pmid">38506687</pub-id></mixed-citation></ref>
<ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>JN</given-names></name> <name><surname>Yu</surname> <given-names>WH</given-names></name> <name><surname>Du</surname> <given-names>HG</given-names></name> <name><surname>Jiang</surname> <given-names>L</given-names></name> <name><surname>Dong</surname> <given-names>XQ</given-names></name> <name><surname>Cao</surname> <given-names>J</given-names></name></person-group>. <article-title>Prospective comparison of redo microvascular decompression and percutaneous balloon compression as primary surgery for recurrent trigeminal neuralgia</article-title>. <source>J Korean Neurosurg Soc</source>. (<year>2018</year>) <volume>61</volume>:<fpage>747</fpage>&#x2013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.3340/jkns.2017.0196</pub-id><pub-id pub-id-type="pmid">30081435</pub-id></mixed-citation></ref>
<ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>ST</given-names></name> <name><surname>Chen</surname> <given-names>JF</given-names></name></person-group>. <article-title>Percutaneous trigeminal ganglion balloon compression for treatment of trigeminal neuralgia, part II: results related to compression duration</article-title>. <source>Surg Neurol</source>. (<year>2003</year>) <volume>60</volume>:<fpage>149</fpage>&#x2013;<lpage>53</lpage>. <comment>discussion 153&#x2013;4</comment>. <pub-id pub-id-type="doi">10.1016/S0090-3019(03)00253-2</pub-id><pub-id pub-id-type="pmid">12900126</pub-id></mixed-citation></ref>
<ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>S</given-names></name> <name><surname>Naito</surname> <given-names>K</given-names></name> <name><surname>Liverneaux</surname> <given-names>P</given-names></name></person-group>. <article-title>Advantages in precision, safety, and aesthetic outcomes of robot-assisted minimally invasive techniques in peripheral nerve microsurgery: a narrative review</article-title>. <source>Advanced Technology in Neuroscience</source>. (<year>2025</year>) <volume>2</volume>(<issue>3</issue>):<fpage>122</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.4103/ATN.ATN-D-24-00036</pub-id></mixed-citation></ref>
<ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>S</given-names></name> <name><surname>Ichihara</surname> <given-names>S</given-names></name> <name><surname>Pruni&#x00E8;res</surname> <given-names>G</given-names></name> <name><surname>Peterson</surname> <given-names>B</given-names></name> <name><surname>Facca</surname> <given-names>S</given-names></name> <name><surname>Xu</surname> <given-names>WD</given-names></name><etal/></person-group> <article-title>Robot-assisted C7 nerve root transfer from the contralateral healthy side: a preliminary cadaver study</article-title>. <source>Hand Surg Rehabil</source>. (<year>2016</year>) <volume>35</volume>:<fpage>95</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.hansur.2015.12.008</pub-id><pub-id pub-id-type="pmid">27117122</pub-id></mixed-citation></ref></ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by"><p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1287608/overview">Carlos A. Bagley</ext-link>, Saint Luke&#x2019;s Marion Bloch Neuroscience Institute, United States</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by"><p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/539680/overview">Christian Scheiwe</ext-link>, University Hospital Freiburg, Germany</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1729512/overview">Jianwei Shi</ext-link>, Capital Medical University, China</p></fn>
</fn-group>
</back>
</article>